Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BGNE
|
Jane Huang
CMO, Hematology |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 100.0% |
$420,240
$280.16 p/Share
|
Sep 29
2020 |
BGNE
|
Jane Huang
CMO, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct | 1,500 Added 50.0% |
$44,235
$29.49 p/Share
|
Sep 29
2020 |
TTD
|
Blake Jeffrey Grayson
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 137 Reduced 0.59% |
$68,500
$500.0 p/Share
|
Sep 29
2020 |
TTD
|
Blake Jeffrey Grayson
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 137 Added 0.59% |
$39,207
$286.18 p/Share
|
Sep 29
2020 |
EFX
|
James M Griggs
SVP & Corp Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 149 Reduced 3.15% |
$23,518
$157.84 p/Share
|
Sep 29
2020 |
EFX
|
Julia A Houston
EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 675 Reduced 12.69% |
$106,542
$157.84 p/Share
|
Sep 29
2020 |
EFX
|
Prasanna Dhore
Chief D&A & Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 75 Reduced 0.54% |
$11,838
$157.84 p/Share
|
Sep 29
2020 |
DDOG
|
Amit Agarwal
Director |
SELL
Open market or private sale
|
Indirect | 8,500 Reduced 72.21% |
$784,125
$92.25 p/Share
|
Sep 29
2020 |
DDOG
|
Amit Agarwal
Director |
BUY
Conversion of derivative security
|
Indirect | 8,500 Added 50.0% |
-
|
Sep 29
2020 |
CTSH
|
Dharmendra Kumar Sinha
President, North America |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 35.81% |
$1,050,000
$70.0 p/Share
|
Sep 29
2020 |
PCVX
|
Ra Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 80,707 Reduced 1.47% |
$4,203,221
$52.08 p/Share
|
Sep 29
2020 |
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 426 Reduced 14.16% |
$109,887
$257.95 p/Share
|
Sep 29
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Sep 29
2020 |
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 0.03% |
$700
$0.14 p/Share
|
Sep 29
2020 |
VLDR
|
Graf Acquisition LLC
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct | 4,079,128 Reduced 67.69% |
-
|
Sep 29
2020 |
GRAY
|
James E Flynn
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,562,500 Added 45.73% |
$25,000,000
$16.0 p/Share
|
Sep 29
2020 |
GRAY
|
James E Flynn
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 3,719,213 Added 35.81% |
-
|
Sep 29
2020 |
IEP
|
Icahn Carl C
Director |
BUY
Other acquisition or disposition
|
Indirect | 8,528,504 Added 3.84% |
$410,135,759
$48.09 p/Share
|
Sep 29
2020 |
AMPY
|
Fir Tree Capital Management LP
Director |
SELL
Open market or private sale
|
Indirect | 441,883 Reduced 4.4% |
$428,627
$0.97 p/Share
|
Sep 29
2020 |
SNEX
|
John Radziwill
Chairman of the Board |
SELL
Open market or private sale
|
Indirect | 6,487 Reduced 1.22% |
$330,967
$51.02 p/Share
|
Sep 29
2020 |
AVGO
|
Hock E Tan
President and CEO |
SELL
Open market or private sale
|
Direct | 78,125 Reduced 24.02% |
$28,710,938
$367.5 p/Share
|
Sep 29
2020 |
AVGO
|
Hock E Tan
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 78,125 Added 19.37% |
$4,113,281
$52.65 p/Share
|
Sep 29
2020 |
GRAY
|
Clarus Lifesciences Iii, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 250,000 Added 11.47% |
$4,000,000
$16.0 p/Share
|
Sep 29
2020 |
GRAY
|
Clarus Lifesciences Iii, L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 1,680,395 Added 34.52% |
-
|
Sep 29
2020 |
WMT
|
Marc E. Lore
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 37,792 Reduced 2.21% |
$5,186,952
$137.25 p/Share
|
Sep 29
2020 |
ASNA
|
Gary Muto
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 710 Reduced 1.56% |
$227
$0.32 p/Share
|
Sep 29
2020 |
ASNA
|
Gary Muto
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,333 Added 2.85% |
-
|
Sep 29
2020 |
ASNA
|
Marisa Baldwin
EVP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct | 227 Reduced 5.85% |
$73
$0.32 p/Share
|
Sep 29
2020 |
ASNA
|
Marisa Baldwin
EVP and CHRO |
BUY
Exercise of conversion of derivative security
|
Direct | 666 Added 14.65% |
-
|
Sep 29
2020 |
ADMQ
|
Marc Johnson
CEO |
BUY
Open market or private purchase
|
Direct | 266,000 Added 0.44% |
$15,960
$0.06 p/Share
|
Sep 29
2020 |
ADMQ
|
Sarah Nelson
COO |
BUY
Open market or private purchase
|
Direct | 155,279 Added 11.52% |
$9,317
$0.06 p/Share
|
Sep 29
2020 |
ADMQ
|
Motasem Khanfur |
BUY
Open market or private purchase
|
Direct | 159,520 Added 18.59% |
$9,571
$0.06 p/Share
|
Sep 29
2020 |
WSTL
|
Mark A Zorko
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 7.47% |
-
|
Sep 29
2020 |
WSTL
|
Cary B Wood
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 7.47% |
-
|
Sep 29
2020 |
WSTL
|
Robert C Penny Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 6.31% |
-
|
Sep 29
2020 |
WSTL
|
Robert W Foskett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 5.55% |
-
|
Sep 29
2020 |
WSTL
|
Scott C Chandler
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 8.63% |
-
|
Sep 29
2020 |
WSTL
|
Kirk R Brannock
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,032 Added 13.87% |
-
|
Sep 29
2020 |
UWHR
|
Jason R Andrew
Chief Operations Officer |
BUY
Open market or private purchase
|
Direct | 262 Added 4.19% |
$1,499
$5.72 p/Share
|
Sep 29
2020 |
UWHR
|
Roger L Dick
President/CEO of UCC |
BUY
Open market or private purchase
|
Direct | 739 Added 50.0% |
$4,227
$5.72 p/Share
|
Sep 29
2020 |
LMB
|
Charles A. Bacon Iii
Director |
BUY
Open market or private purchase
|
Direct | 5,263 Added 1.29% |
$49,472
$9.4 p/Share
|
Sep 29
2020 |
FXNC
|
Gerald F Smith Jr
Director |
BUY
Open market or private purchase
|
Direct | 100 Added 3.06% |
$1,460
$14.6 p/Share
|
Sep 29
2020 |
GLSI
|
David Mc Williams
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 171,622 Added 21.72% |
-
|
Sep 29
2020 |
GLSI
|
Kenneth Hallock
Director |
BUY
Exercise of conversion of derivative security
|
Indirect | 116,575 Added 9.77% |
-
|
Sep 29
2020 |
GLSI
|
Snehal Patel
CEO and CFO |
BUY
Exercise of conversion of derivative security
|
Indirect | 1,360,635 Added 21.9% |
-
|
Sep 29
2020 |
GLSI
|
Snehal Patel
CEO and CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 304,489 Added 20.68% |
-
|
Sep 29
2020 |
PTE
|
Cameron J. Hoyler
Gen. Counsel & Exec. VP |
SELL
Open market or private sale
|
Direct | 936 Reduced 0.16% |
$945
$1.01 p/Share
|
Sep 29
2020 |
FFNW
|
Joann E Lee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,539 Added 3.5% |
$32,276
$9.12 p/Share
|
Sep 29
2020 |
FFNW
|
Roger H Molvar
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,539 Added 23.85% |
$32,276
$9.12 p/Share
|
Sep 29
2020 |
FFNW
|
Richard M Riccobono
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,539 Added 15.39% |
$32,276
$9.12 p/Share
|
Sep 29
2020 |